Ottawa, Canada, firm gains FDA approval to test potential COVID-19 drug
Following on promising mice-based research that indicated THC might provide effective protection from acute respiratory distress syndrome (ARDS), Ottawa, Canada-based Tetra Bio-Pharma has received FDA approval for Phase 1 testing of its synthetic cannabinoid drug, ARDS-003. ARDS is a severe lung injury that leads to significant morbidity and mortality, especiallyContinue Reading